Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease
Authors
Varlotto, John M.Voland, Richard
McKie, Kerrie
Flickinger, John C.
DeCamp, Malcolm M.
Maddox, Debra
Rava, Paul
Fitzgerald, Thomas J.
Graeber, Geoffrey
Rassaei, Negar
Oliveira, Paulo
Ali, Suhail
Belani, Chandra
Glanzman, Jonathan
Wakelee, Heather A.
Patel, Manali
Baima, Jennifer
Zhang, Jianying
Walsh, William
UMass Chan Affiliations
Department of Quantitative Health SciencesDepartment of Orthopedics and Rehabilitation
Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
Department of Surgery, Division of Thoracic Surgery
Department of Medical Oncology
Department of Radiology
Department of Radiation Oncology
Document Type
Journal ArticlePublication Date
2018-04-01Keywords
Disparitiesinsurance
lung cancer
marriage
metastatic lung cancer
outcomes
race
socio-economic factors
Clinical Epidemiology
Demography, Population, and Ecology
Epidemiology
Medicine and Health
Neoplasms
Race and Ethnicity
Respiratory Tract Diseases
Metadata
Show full item recordAbstract
To investigate the interrelation between economic, marital, and known histopathologic/therapeutic prognostic factors in presentation and survival of patients with lung cancer in nine different ethnic groups. A retrospective review of the SEER database was conducted through the years 2007-2012. Population differences were assessed via chi-square testing. Multivariable analyses (MVA) were used to detect overall survival (OS) differences in the total population (TP, N = 153,027) and for those patients presenting with Stage IV (N = 70,968). Compared to Whites, Blacks were more likely to present with younger age, male sex, lower income, no insurance, single/widowed partnership, less squamous cell carcinomas, and advanced stage; and experience less definitive surgery, lower OS, and lung cancer-specific (LCSS) survival. White Hispanics presented with younger age, higher income, lower rates of insurance, single/widowed partnership status, advanced stage, more adenocarcinomas, and lower rates of definitive surgery, but no difference in OS and LCSS than Whites. In the TP and Stage IV populations, MVAs revealed that OS was better or equivalent to Whites for all other ethnic groups and was positively associated with insurance, marriage, and higher income. Blacks presented with more advanced disease and were more likely to succumb to lung cancer, but when adjusted for prognostic factors, they had a better OS in the TP compared to Whites. Disparities in income, marital status, and insurance rather than race affect OS of patients with lung cancer. Because of their presentation with advanced disease, Black and Hispanics are likely to have increased benefit from lung cancer screening.Source
Cancer Med. 2018 Apr;7(4):1211-1220. doi: 10.1002/cam4.1430. Epub 2018 Mar 13. Link to article on publisher's site
DOI
10.1002/cam4.1430Permanent Link to this Item
http://hdl.handle.net/20.500.14038/40604PubMed ID
29533006Related Resources
Rights
© 2018 The Authors. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Distribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.1002/cam4.1430
Scopus Count
Except where otherwise noted, this item's license is described as © 2018 The Authors. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.